ENVB

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended June 30, 2009, for Spatializer Audio Laboratories, Inc. (Note: The input metadata listed "Enveric Biosciences," but the filing text explicitly identifies the registrant as Spatializer Audio Laboratories, Inc.). The company is a Delaware corporation classified as a shell company and a smaller reporting company. Spatializer ceased commercial operations in 2006 after selling substantially all of its intellectual property assets to DTS, Inc. in July 2007. The company currently has no operating activities and is seeking a merger, acquisition, or business combination to continue as a public entity.

Key Financial Metrics

Note: The filing reports no debt (Notes Payable were repaid in prior periods). The company has significant Net Operating Loss (NOL) carryforwards of approximately $26.2 million, though their utility is limited by annual caps and potential change-in-control restrictions.

Material Changes vs. Prior Period

• Net Loss Reduction: The net loss for the three months ended June 30, 2009, was $(13,629), a significant decrease from the $(36,484) loss in the same period in 2008. This improvement is attributed to reduced General and Administrative expenses ($13,601 vs. $37,999) due to the suspension of operations.
• Cash Position: Cash and cash equivalents declined from $66,833 at December 31, 2008, to $13,399 at June 30, 2009. This decrease of approximately $53,434 was driven by operating expenses required to maintain the company as a public entity and one-time compliance costs.
• Liabilities: Total current liabilities decreased from $21,206 to $1,143, primarily due to the payment of accrued professional fees and accounts payable.

Outlook, Risks, and Subsequent Events

Going Concern Uncertainty: The filing explicitly states that the company's circumstances, including significant operating losses and limited working capital, raise substantial doubt about its ability to continue as a going concern. The financial statements do not include adjustments that might result from this uncertainty. Management's plan relies on completing a merger or acquisition or raising additional capital.

Subsequent Event (Change in Control): On July 7, 2009, the company entered into subscription agreements with six purchasers (including the CEO, CFO, and a Director) to sell 13,500,000 shares for $36,450 (approximately $0.0027 per share) and future services. This transaction represented approximately 67.5% of the outstanding stock at the time and resulted in a change in control of the company. Following this transaction, the total shares outstanding increased to 20,000,000.

Risks: The company faces risks related to the lack of liquidity, the failure to secure a merger/acquisition, and the potential expiration of NOL carryforwards due to the change in control. There are no material legal proceedings pending as of August 10, 2009.

Investor Verification Checklist

• Shell Status: Verify the company's status as a shell company with no active operations and its reliance on a merger/acquisition for survival.
• Liquidity Runway: Confirm the sufficiency of the $36,450 raised in July 2009 to cover ongoing public company compliance costs until a transaction is completed.
• Change in Control: Review the implications of the July 2009 private placement, which resulted in a change of control and may limit the utility of the $26.2 million NOL carryforwards.
• Dilution: Note the significant increase in shares outstanding (from 6.5 million to 20 million) following the subsequent event, which heavily dilutes pre-July 2009 shareholders.
• Management Alignment: Observe that the primary investors in the subsequent event were existing officers and directors, indicating insider confidence but also potential concentration of ownership.